Legend Biotech (LEGN) Goodwill & Intangibles (2019 - 2025)
Legend Biotech's (LEGN) quarterly Goodwill & Intangibles came in at $2.1 million in Q2 2025, down 22.91% YoY from $2.8 million in Q2 2024, and down 74.91% on a QoQ basis from $8.5 million in Q1 2025.
Analysis
Legend Biotech (LEGN) Goodwill & Intangibles (2019 - 2025) Analysis & Trends
Legend Biotech (LEGN) has 7 years of Goodwill & Intangibles data on file, last reported at $2.1 million in Q2 2025.
- Quarterly Goodwill & Intangibles fell 22.91% year-over-year to $2.1 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $2.1 million (down 22.91% YoY) and the FY2024 annual result came in at $2.2 million, down 46.81% from the prior year.
- Goodwill & Intangibles retreated to $2.1 million in Q2 2025, from $8.5 million in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $8.5 million in Q1 2025 to a low of $4081.0 in Q1 2021.
- A 5-year average of $3.7 million and a median of $3.3 million in 2022 frame the typical range for Goodwill & Intangibles.
- Annual changes were most pronounced in 2021 — Goodwill & Intangibles soared 521205.18% — and 2023, when it sank 49.32%.
- Tracing LEGN's Goodwill & Intangibles over 5 years: stood at $6.4 million in 2021, then sank by 46.75% to $3.4 million in 2022, then advanced by 19.13% to $4.1 million in 2023, then plunged by 46.81% to $2.2 million in 2024, then retreated by 1.06% to $2.1 million in 2025.
- The last three Goodwill & Intangibles figures came in at $2.1 million (Q2 2025), $8.5 million (Q1 2025), and $2.2 million (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 2.14 Mn |
| Mar 31, 2025 | 2.08 Mn |
| Dec 31, 2024 | 2.16 Mn |
| Sep 30, 2024 | 2.51 Mn |
| Jun 30, 2024 | 2.77 Mn |
| Mar 31, 2024 | 3.15 Mn |
| Dec 31, 2023 | 4.06 Mn |
| Sep 30, 2023 | 4.01 Mn |
| Jun 30, 2023 | 2.47 Mn |
| Mar 31, 2023 | 2.29 Mn |
| Dec 31, 2022 | 3.41 Mn |
| Mar 31, 2022 | 4.52 Mn |
| Dec 31, 2021 | 4.68 Mn |
| Sep 30, 2021 | 5.43 Mn |
| Jun 30, 2021 | 4.68 Mn |
| Mar 31, 2021 | 4.08 Mn |
| Dec 31, 2020 | 2.85 Mn |
| Sep 30, 2020 | 1.04 Mn |
| Jun 30, 2020 | 978,000.00 |
| Dec 31, 2019 | 519,000.00 |